Dr. Richard Raymond - Antibiotics and Food Safety: Perceptions vs. RealityJohn Blue
"Antibiotics and Food Safety: Perceptions vs. Reality - Dr. Richard Raymond, Former Undersecretary for Food Safety, U.S. Department of Agriculture, from the 2014 Minnesota Pork Congress, January 14-15, Minneapolis, MN, USA.
More presentations at http://www.swinecast.com/2014-minnesota-pork-congress"
Antibiotic Resistance form food of animal origint- Debatable issueAsima Zehra
Contribution to the development of antibiotic resistance is multifactorial wherein human medicine plays a major role and food of animal origin are least to bother.
Dr. Brian Lubbers - Animal Agriculture's Contribution to Antibiotic Resistanc...John Blue
Animal Agriculture's Contribution to Antibiotic Resistance - What Should (& Should Not) Be On The Table - Dr. Brian Lubbers, Kansas State University College of Veterinary Medicine, Director of Clinical Microbiology, from the 2014 NIAA Symposium on Antibiotics Use and Resistance: Moving Forward Through Shared Stewardship, November 12-14, 2014, Atlanta, Georgia, USA.
More presentations at http://www.swinecast.com/2014-niaa-antibiotics-moving-forward-through-shared-stewardship
Dr. Tom Chiller - International Activities in Antimicrobial ResistanceJohn Blue
International Activities in Antimicrobial Resistance - Dr. Tom Chiller, Associate Director for Epidemiologic Science, Division of Foodborne, Waterborne, and Environmental Diseases, US Centers for Disease Control and Prevention, from the 2014 NIAA Symposium on Antibiotics Use and Resistance: Moving Forward Through Shared Stewardship, November 12-14, 2014, Atlanta, Georgia, USA.
More presentations at http://www.swinecast.com/2014-niaa-antibiotics-moving-forward-through-shared-stewardship
Antimicrobial resistance of Salmonella enterica in pork and vegetable serving...ILRI
Poster by Dickson Ndoboli, Martin Heilmann, Kristina Roesel, Peter-Henning Clausen, Edward Wampande, Delia Grace, Thomas Alter and Stephan Huehn presented at the first joint conference of the Association of Institutions for Tropical Veterinary Medicine and the Society of Tropical Veterinary Medicine, Berlin, Germany, 4–8 September 2016.
Antimicrobial resistance as an emerging food-borne infectious diseaseJean Jacques Bernatas
Food safety is also about acquired antimicrobial resistance in big farms, and its spread in the environment. Be a smart consumer, a smart producer, and a smart patient to contributing to get antimicrobial resistance under control.
Dr. Richard Raymond - Antibiotics and Food Safety: Perceptions vs. RealityJohn Blue
"Antibiotics and Food Safety: Perceptions vs. Reality - Dr. Richard Raymond, Former Undersecretary for Food Safety, U.S. Department of Agriculture, from the 2014 Minnesota Pork Congress, January 14-15, Minneapolis, MN, USA.
More presentations at http://www.swinecast.com/2014-minnesota-pork-congress"
Antibiotic Resistance form food of animal origint- Debatable issueAsima Zehra
Contribution to the development of antibiotic resistance is multifactorial wherein human medicine plays a major role and food of animal origin are least to bother.
Dr. Brian Lubbers - Animal Agriculture's Contribution to Antibiotic Resistanc...John Blue
Animal Agriculture's Contribution to Antibiotic Resistance - What Should (& Should Not) Be On The Table - Dr. Brian Lubbers, Kansas State University College of Veterinary Medicine, Director of Clinical Microbiology, from the 2014 NIAA Symposium on Antibiotics Use and Resistance: Moving Forward Through Shared Stewardship, November 12-14, 2014, Atlanta, Georgia, USA.
More presentations at http://www.swinecast.com/2014-niaa-antibiotics-moving-forward-through-shared-stewardship
Dr. Tom Chiller - International Activities in Antimicrobial ResistanceJohn Blue
International Activities in Antimicrobial Resistance - Dr. Tom Chiller, Associate Director for Epidemiologic Science, Division of Foodborne, Waterborne, and Environmental Diseases, US Centers for Disease Control and Prevention, from the 2014 NIAA Symposium on Antibiotics Use and Resistance: Moving Forward Through Shared Stewardship, November 12-14, 2014, Atlanta, Georgia, USA.
More presentations at http://www.swinecast.com/2014-niaa-antibiotics-moving-forward-through-shared-stewardship
Antimicrobial resistance of Salmonella enterica in pork and vegetable serving...ILRI
Poster by Dickson Ndoboli, Martin Heilmann, Kristina Roesel, Peter-Henning Clausen, Edward Wampande, Delia Grace, Thomas Alter and Stephan Huehn presented at the first joint conference of the Association of Institutions for Tropical Veterinary Medicine and the Society of Tropical Veterinary Medicine, Berlin, Germany, 4–8 September 2016.
Antimicrobial resistance as an emerging food-borne infectious diseaseJean Jacques Bernatas
Food safety is also about acquired antimicrobial resistance in big farms, and its spread in the environment. Be a smart consumer, a smart producer, and a smart patient to contributing to get antimicrobial resistance under control.
Antimicrobial resistance (AMR) in N. gonorrhoeae (GC) - global problem but v...Игорь Шадеркин
Antimicrobial resistance (AMR) in N. gonorrhoeae (GC) - global problem but valid data are lacking in many geographic areas
Magnus Unemo, PhD, Assoc. Professor
Reference Laboratory for Pathogenic Neisseria
Department of Clinical Microbiology
Örebro University Hospital
Sweden
Fighting the growing threat of antimicrobial resistance webinar4 All of Us
Lord Jim O’Neill, the UK Commercial Secretary to the Treasury and Chair of the Review on Antimicrobial Resistance, recently released a report laying out recommendations to fight the global threat of antimicrobial resistance (AMR).
Overuse of antibiotics, especially of broad spectrum antibiotics rather than targeted narrow spectrum therapies, has led to an increase in drug-resistant bacterial infections. This emerging health issue is poised to have devastating global consequences, making it impossible to treat previously curable diseases. AMR already contributes to 700,000 deaths a year, and the report warns that it could cause 10 million deaths a year and $100 trillion in lost global productivity by 2050 if nothing is done to stop its spread.
In recent years, advances in diagnostic technology have made rapid point-of-care testing possible for many diseases – enabling providers to immediately prescribe the most appropriate therapy during the course of a patient’s visit.
This webinar will focused on the importance of understanding the need for diagnostics, what is being done in development and the solutions that are available now.
Dr. William Flynn - FDA Antibiotics StrategyJohn Blue
FDA Antibiotics Strategy - Dr. William Flynn, Deputy Director for Science Policy, Food and Drug Administration Center for Veterinary Medicine, from the 2014 NIAA Symposium on Antibiotics Use and Resistance: Moving Forward Through Shared Stewardship, November 12-14, 2014, Atlanta, Georgia, USA.
More presentations at http://www.swinecast.com/2014-niaa-antibiotics-moving-forward-through-shared-stewardship
In June this year Darren Parris and I visited Novus in St Charles, Missouri, to celebrate their 25-year anniversary. Among the revelries (including a personal highlight of a Cardinals baseball match) we were invited to some insightful talks at the Novus Media Jam. One of these talks specifically concerned the Antibiotic Free Movement or ABF, where the ‘sub-therapeutic’ use of antibiotics and the many alternatives Novus offer were discussed.
Antibiotics
History and development of antibiotics
Decline of antibiotics
Bacteriophage: nature’s most abundant antibiotics
Phage specificity, resistance, transduction, lysis
Emergence of phages
Phage Case studies
Challenges to mainstream commercialization
Alternatives to Antibiotic Use in Food Animal ProductionPewEnvironment
Stephen Jay, M.D., professor of Medicine and Public Health and past founding chair, Department of Public Health, Indiana University School of Medicine.
Edible vaccines hold great promise as a cost-effective, easy-to-administer, easy-to-store, fail-safe and socioculturally readily acceptable vaccine delivery system, especially for the poor developing countries. It involves introduction of selected desired genes into plants and then inducing these altered plants to manufacture the encoded proteins. Introduced as a concept about a decade ago, it has become a reality today. A variety of delivery systems have been developed. Initially thought to be useful only for preventing infectious diseases, it has also found application in prevention of autoimmune diseases, birth control, cancer therapy, etc. Edible vaccines are currently being developed for a number of human and animal diseases. There is growing acceptance of transgenic crops in both industrial and developing countries. Resistance to genetically modified foods may affect the future of edible vaccines. They have passed the major hurdles in the path of an emerging vaccine technology. Various technical obstacles, regulatory and non-scientific challenges, though all seem surmountable, need to be overcome. This review attempts to discuss the current status and future of this new preventive modality.
Overview of Laws Regulating Antibiotics in Livestock & Policy Positions of St...Cari Rincker
This was prepared for a presentation for the Association for the Bar for the City of New York's Committee on Animal Law & Health Law Committee. Outline with more detail and citations is available at http://www.jdsupra.com/legalnews/overviews-of-laws-regulating-antibiotics-15572/.
Felicia Wu
John A. Hannah Distinguished Professor
Department of Food Science and Human Nutrition
Department of Agricultural, Food, and Resource Economics
Dr. Robert Tauxe - Public Health Concerns About Resistant Foodborne InfectionsJohn Blue
Public Health Concerns About Resistant Foodborne Infections - Dr. Robert Tauxe, Deputy Director, Division of Foodborne, Waterborne and Environmental Infections, Centers for Disease Control and Prevention, from the 2013 NIAA Symposium Bridging the Gap Between Animal Health and Human Health, November 12-14, 2013, Kansas City, MO, USA.
More presentations at http://www.trufflemedia.com/agmedia/conference/2013-niaa-antibiotics-bridging-the-gap-animal-health-human-health
The use of antimicrobial in humans and animals, the consequences of this use, the political and economic barriers to improve prudent use and possible solutions for this problem.
Who is responsible for emergence and spread of AMR? How ?o handle it?Bhoj Raj Singh
Is there anyone who is responsible for AMR? Everyone say no, or if accept, accept it partly. The community which is most readily accept the partial responsibility is Veterinarians and with some reluctance are the Medicos but others will either say Ï am not or will point this or that fellow or will show innocence or utter irrelevance. Who are those vets and medicos readily accept the responsibility or painted for AMR? All those from developing and poor countries, why? In India, there is a saying, “wife of a poor is Bhabhi of all”, that is poor are legalized to be blamed. All the responsible keep them behind thick curtains of the legal, philanthropic and humanitarian veil or with their right to Veto and might. In this presentation tried to understand the role of those behind veils and those are blamed.
Dr. Paul Ruen - The future of Antibiotic Use: Are you, your feed mill and vet...John Blue
The future of Antibiotic Use: Are you, your feed mill and veterinarian ready for January 1, 2017? How did we get here? What does it mean? - Dr. Paul Ruen, Fairmont Veterinary Clinic, from the 2016 Minnesota Pork Congress, January 18 - 20, 2016, Minneapolis, MN, USA.
More presentations at http://www.swinecast.com/2016-minnesota-pork-congress
Dr. Richard Raymond - Antibiotics used in animals Raised for Food - Perceptio...John Blue
Antibiotics used in animals Raised for Food - Perception vs. reality - Dr. Richard Raymond, M.D., former U.S. Department of Agriculture Undersecretary for Food Safety, from the 2015 World Pork Expo, June 3 - 5, 2015, Des Moines, IA, USA.
More presentations at http://www.swinecast.com/2015-world-pork-expo
Bridging the Autoimmune Abyss through New DiscoveriesDrBonnie360
A comprehensive collection of our autoimmunity research done in an effort to help bridge the gap for the large and growing needs of the autoimmune community. This bibliography is a sneak peak at an upcoming white paper for the lonely voices of autoimmune disease.
Topics Include:
Prevalence & Incidence
Immunology
Polyautoimmunity
Current Treatments & Therapies
The Microbiome
Data and Digital Tools
Causes of Autoimmune Disease
Prevention & Lifestyle Modification
An Antibiotic is given for the treatment of an infection caused by bacteria. Antibiotics target microorganisms such as bacteria, fungi and parasites. However, they are not effective against viruses. If you have an infection it is important to know whether it is caused by bacteria or a virus.
Antimicrobial resistance (AMR) in N. gonorrhoeae (GC) - global problem but v...Игорь Шадеркин
Antimicrobial resistance (AMR) in N. gonorrhoeae (GC) - global problem but valid data are lacking in many geographic areas
Magnus Unemo, PhD, Assoc. Professor
Reference Laboratory for Pathogenic Neisseria
Department of Clinical Microbiology
Örebro University Hospital
Sweden
Fighting the growing threat of antimicrobial resistance webinar4 All of Us
Lord Jim O’Neill, the UK Commercial Secretary to the Treasury and Chair of the Review on Antimicrobial Resistance, recently released a report laying out recommendations to fight the global threat of antimicrobial resistance (AMR).
Overuse of antibiotics, especially of broad spectrum antibiotics rather than targeted narrow spectrum therapies, has led to an increase in drug-resistant bacterial infections. This emerging health issue is poised to have devastating global consequences, making it impossible to treat previously curable diseases. AMR already contributes to 700,000 deaths a year, and the report warns that it could cause 10 million deaths a year and $100 trillion in lost global productivity by 2050 if nothing is done to stop its spread.
In recent years, advances in diagnostic technology have made rapid point-of-care testing possible for many diseases – enabling providers to immediately prescribe the most appropriate therapy during the course of a patient’s visit.
This webinar will focused on the importance of understanding the need for diagnostics, what is being done in development and the solutions that are available now.
Dr. William Flynn - FDA Antibiotics StrategyJohn Blue
FDA Antibiotics Strategy - Dr. William Flynn, Deputy Director for Science Policy, Food and Drug Administration Center for Veterinary Medicine, from the 2014 NIAA Symposium on Antibiotics Use and Resistance: Moving Forward Through Shared Stewardship, November 12-14, 2014, Atlanta, Georgia, USA.
More presentations at http://www.swinecast.com/2014-niaa-antibiotics-moving-forward-through-shared-stewardship
In June this year Darren Parris and I visited Novus in St Charles, Missouri, to celebrate their 25-year anniversary. Among the revelries (including a personal highlight of a Cardinals baseball match) we were invited to some insightful talks at the Novus Media Jam. One of these talks specifically concerned the Antibiotic Free Movement or ABF, where the ‘sub-therapeutic’ use of antibiotics and the many alternatives Novus offer were discussed.
Antibiotics
History and development of antibiotics
Decline of antibiotics
Bacteriophage: nature’s most abundant antibiotics
Phage specificity, resistance, transduction, lysis
Emergence of phages
Phage Case studies
Challenges to mainstream commercialization
Alternatives to Antibiotic Use in Food Animal ProductionPewEnvironment
Stephen Jay, M.D., professor of Medicine and Public Health and past founding chair, Department of Public Health, Indiana University School of Medicine.
Edible vaccines hold great promise as a cost-effective, easy-to-administer, easy-to-store, fail-safe and socioculturally readily acceptable vaccine delivery system, especially for the poor developing countries. It involves introduction of selected desired genes into plants and then inducing these altered plants to manufacture the encoded proteins. Introduced as a concept about a decade ago, it has become a reality today. A variety of delivery systems have been developed. Initially thought to be useful only for preventing infectious diseases, it has also found application in prevention of autoimmune diseases, birth control, cancer therapy, etc. Edible vaccines are currently being developed for a number of human and animal diseases. There is growing acceptance of transgenic crops in both industrial and developing countries. Resistance to genetically modified foods may affect the future of edible vaccines. They have passed the major hurdles in the path of an emerging vaccine technology. Various technical obstacles, regulatory and non-scientific challenges, though all seem surmountable, need to be overcome. This review attempts to discuss the current status and future of this new preventive modality.
Overview of Laws Regulating Antibiotics in Livestock & Policy Positions of St...Cari Rincker
This was prepared for a presentation for the Association for the Bar for the City of New York's Committee on Animal Law & Health Law Committee. Outline with more detail and citations is available at http://www.jdsupra.com/legalnews/overviews-of-laws-regulating-antibiotics-15572/.
Felicia Wu
John A. Hannah Distinguished Professor
Department of Food Science and Human Nutrition
Department of Agricultural, Food, and Resource Economics
Dr. Robert Tauxe - Public Health Concerns About Resistant Foodborne InfectionsJohn Blue
Public Health Concerns About Resistant Foodborne Infections - Dr. Robert Tauxe, Deputy Director, Division of Foodborne, Waterborne and Environmental Infections, Centers for Disease Control and Prevention, from the 2013 NIAA Symposium Bridging the Gap Between Animal Health and Human Health, November 12-14, 2013, Kansas City, MO, USA.
More presentations at http://www.trufflemedia.com/agmedia/conference/2013-niaa-antibiotics-bridging-the-gap-animal-health-human-health
The use of antimicrobial in humans and animals, the consequences of this use, the political and economic barriers to improve prudent use and possible solutions for this problem.
Who is responsible for emergence and spread of AMR? How ?o handle it?Bhoj Raj Singh
Is there anyone who is responsible for AMR? Everyone say no, or if accept, accept it partly. The community which is most readily accept the partial responsibility is Veterinarians and with some reluctance are the Medicos but others will either say Ï am not or will point this or that fellow or will show innocence or utter irrelevance. Who are those vets and medicos readily accept the responsibility or painted for AMR? All those from developing and poor countries, why? In India, there is a saying, “wife of a poor is Bhabhi of all”, that is poor are legalized to be blamed. All the responsible keep them behind thick curtains of the legal, philanthropic and humanitarian veil or with their right to Veto and might. In this presentation tried to understand the role of those behind veils and those are blamed.
Dr. Paul Ruen - The future of Antibiotic Use: Are you, your feed mill and vet...John Blue
The future of Antibiotic Use: Are you, your feed mill and veterinarian ready for January 1, 2017? How did we get here? What does it mean? - Dr. Paul Ruen, Fairmont Veterinary Clinic, from the 2016 Minnesota Pork Congress, January 18 - 20, 2016, Minneapolis, MN, USA.
More presentations at http://www.swinecast.com/2016-minnesota-pork-congress
Dr. Richard Raymond - Antibiotics used in animals Raised for Food - Perceptio...John Blue
Antibiotics used in animals Raised for Food - Perception vs. reality - Dr. Richard Raymond, M.D., former U.S. Department of Agriculture Undersecretary for Food Safety, from the 2015 World Pork Expo, June 3 - 5, 2015, Des Moines, IA, USA.
More presentations at http://www.swinecast.com/2015-world-pork-expo
Bridging the Autoimmune Abyss through New DiscoveriesDrBonnie360
A comprehensive collection of our autoimmunity research done in an effort to help bridge the gap for the large and growing needs of the autoimmune community. This bibliography is a sneak peak at an upcoming white paper for the lonely voices of autoimmune disease.
Topics Include:
Prevalence & Incidence
Immunology
Polyautoimmunity
Current Treatments & Therapies
The Microbiome
Data and Digital Tools
Causes of Autoimmune Disease
Prevention & Lifestyle Modification
An Antibiotic is given for the treatment of an infection caused by bacteria. Antibiotics target microorganisms such as bacteria, fungi and parasites. However, they are not effective against viruses. If you have an infection it is important to know whether it is caused by bacteria or a virus.
WTF - Why the Future Is Up to Us - pptx versionTim O'Reilly
This is the talk I gave January 12, 2017 at the G20/OECD Conference on the Digital Future in Berlin. I talk about fitness landscapes as applied to technology and business, the role of unchecked financialization in the state of our politics and economy, and why technology really wants to create jobs, not destroy them. (There is a separate PDF version, but some readers said the notes were too fuzzy to read.)
Dr. Robert Tauxe - Antimicrobial Resistance and The Human-Animal Interface: T...John Blue
Antimicrobial Resistance and The Human-Animal Interface: The Public Health Concerns - Dr. Robert Tauxe, Deputy Director, Division of Foodborne, Waterborne and Environmental Diseases, US Centers for Disease Control and Prevention, from the 2014 NIAA Symposium on Antibiotics Use and Resistance: Moving Forward Through Shared Stewardship, November 12-14, 2014, Atlanta, Georgia, USA.
More presentations at http://www.swinecast.com/2014-niaa-antibiotics-moving-forward-through-shared-stewardship
Infectious diseases of livestock are most costly and hazardous problem facing the Agri-food industry
Adversely affect animal production and economics by increasing the cost of production and decreasing the production rate
Occurrence and antibiotic susceptibility of Streptococcus pyogenes isolated f...Premier Publishers
A total of 24 throat samples were collected from Patients in Federal Medical Centre Umuahia, Abia State, to evaluate the prevalence of S. pyogenes and its antibiotic sensitivity. 17(70.8%) samples yielded Streptococcus pyogenes which was identified following some identification test. The incident rate was higher among those within the age of 5-25 years (53%). 58% of the isolate were from females. S. pyogenens showed 100% sensitivity to levofloxacin, vancomycin, penicillin G and amoxicillin and was resistant to tetracycline (58.8%). Penicillin, amoxicillin, levofloxacin and vancomycin could serve at first line drug of choice for the treatment of S. pyogenes infection.
Comparative Study of the Prevalence and Antibiogram of Bacterial Isolates fro...iosrjce
The study compared the prevalence and antibiogram of bacterial isolates from the urinary and
genital tracts of pregnant women attending ante-natal clinics in Imo State. Urine and High vaginal swab (HVS)
samples were collected from across the three geopolitical zones of Imo State (Owerri, Orlu and Okigwe).
Federal Medical Centre (FMC) Owerri, Imo State University Teaching Hospital (IMSUTH) Orlu and General
Hospital Okigwe (GHO) were used as focal points. A total of 1197 samples were obtained from women and
used. Infection was significantly more with the urine samples than the HVS samples (P < 0.05) while
polymicrobial growth was more observed with the HVS samples. Escherichia coli was the predominantly
isolated organism (38.3%) from the urine samples while Staphylococcus aureus (29.1%) was the predominant
bacterial isolates in HVS. Other commonly isolated bacterial species include; Enterococcus faecalis and
Staphylococcus epidermidis, Klebsiella pneumoniae, Proteus mirabilis and Bacteriodes were solely isolated
from urine while Lactobacillus was solely isolated from HVS. Overall antibiogram showed ciprofloxacin to be
the most effective antibiotic followed by nalidixic acid and pefloxac in for both specimens. Generally, multidrug
resistance was more in urine isolates (55.7%) than vaginal isolates (53.6%) with many showing the same
resistance patterns. The rate of multi/drug resistance in both samples is high (>50%) and worrisome. These call
for routine HVS as well as urine culture to be carried out on all antenatal women to ensure holistic antenatal care/ management.
Transfer of resistant bacteria from animals to humans
1. Transfer of resistant bacteria from animals to humans – relation to antibiotic use as growth promoters and therapeutics Niels Frimodt-Møller Professor, MD, DMSc. Dept. for Microbiological Surveillance and Research Statens Serum Institut Copenhagen Denmark
2. Antibiotic resistance: Clinical consequence * P < 0.05 1,29 (1,04 – 1,59)* S.pneumoniae : PenR vs PenS Tleyjeh et al. CID 2006;42:778-97 2,52 (1,9 - 3,4)* Enterococcus : VR vs VS DiazGranados et al. CID 2005;41:327-33 4,41 (1,03 – 18,81)* E. coli : FQ-R vs FQ-S Lautenbach et al. CID 2005;41:923-9 1,93 (1,54 – 2,42)* S.aureus : MR vs MS Cosgrove et al. CID 2003;36:53-59 Odds Ratio (95% CI) for mortality
3.
4.
5.
6.
7.
8. Transfer of VRE from animal to humans: Scientific evidence Same type VRE in poultry and farmer Simonsen et al. Microb Drug Resist. 1998; 4: 313-8. Same VRE in poultry before and after slaughter Aarestrup et al. APMIS 1998; 106:606–22 VRE in food . Wegener et al. Int J Food Microbiol 1997; 35:57–66. Robredo Int J Food Microbiol. 2000; 54: 197-204. VRE carriers in countries, where avoparcin used, but not else Ieven [abstract LB-8, 41st ICAAC, 2001. Klare et al. Microb Drug Resist. 1999; 5: 45-52. Klare et al. Microb Drug Resist. 1995;1: 265-72. Same type VRE in pigs and patients Jensen et al. AAC 1999; 43:724–5; Hammerum et al. JAC 2004; 53:547–9.
9. Results of ban of growth promoters Avoparcin and Virginiamycin in Denmark
10. Fecal carrier rates of Vancomycin Resistant E. faecium (VRE) in non-hospitalised humans 12/100 11/40 6/100 13/400 1/670 3/169 2/6023 % pos with VRE Ban of Avoparcin Van den Bogard et al., JAC 2000, 46: 146 Van den Auwera et al. JID 1996, 173: Klare et al. Microb Drug Resist. 1999;5:45-52. Gambarotto et al. J Clin Microbiol. 2000; 38: 620–624. Torell et al. J Clin Microbiol . 1999; 37: 3509–3513 Kolar et al.J Med Microbiol. 2005; 54: 965-7. . S F D NL D Cz D
11. Significant decrease of VRE infections and colonization rates in patients at hospital admission after AGP ban Colonization at admission Infections in hospitals W. Witte, personal comm. M. Leven et.al. ICAAC 2001 Germany Belgium N=335 N=353 % vanA % vanA
12.
13. Use of Streptogramin Growth Promoters in Poultry and Isolation of Streptogramin-Resistant Enterococcus faecium from Humans Kieke et al. The Journal of Infectious Diseases 2006; 194:1200–8 Minnesota, Wiscosin, USA